IL-1β antibodies, for instance, have shown promise in reducingmyocardial infarction and angina in patients with atherosclerosis [9, 101].Additionally, IL-1β receptor antagonists effectively prevent myocardialdysfunction and arrhythmias in Kawasaki disease, underscoring the potential ofIL-1β-targeted treatments for arrhythmias [102]. This evidence concerns the gene IL1B and Arrhythmia.